Development and Testing of an Electronic Visit for COPD Early Detection and Smoking Cessation
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 125
- Locations
- 1
- Primary Endpoint
- Number of Participants at Month 1 and Month 3 With At Least 1 Quit Attempt
Study Overview
Brief Summary
The goal of this work is to develop, refine, and pilot test an electronic visit (e-visit) to: 1) deliver smoking cessation treatment to adults at risk for COPD and 2) to improve rates of COPD early detection and accurate diagnosis. The investigators will conduct a pilot RCT of the COPD/smoking cessation e-visit as compared to treatment as usual (TAU), with primary objective to provide effect size estimates for a larger RCT.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Health Services Research
- Masking
- None
Eligibility Criteria
- Ages
- 40 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •current cigarette smoker,
- •enrolled in MUSC's Epic MyChart program or willing to sign up for MyChart,
- •possess a valid e-mail address that is checked daily,
- •English fluency, and
- •owner of an iOS or Android-compatible smartphone and a webcam-enabled device
Exclusion Criteria
- •COPD on a patient's problem list within Epic.
Arms & Interventions
COPD/smoking cessation electronic visit (e-visit)
This group will be sent 1) an invitation to complete an electronic visit (e-visit) focused on cigarette smoking, quitting smoking, and respiratory symptoms, 2) an invitation to complete a follow-up e-visit one-month after the initial e-visit, and if needed, 3) a home spirometry test with instructions on how to video themselves completing a lung functioning test via the device within an additional e-visit.
Intervention: smoking cessation, early COPD detection, electronic visit (Behavioral)
Treatment as Usual (TAU)
This group will be provided information about the state quitline and about the importance of quitting smoking and it will be recommended that they contact their PCP to schedule a medical visit to discuss quitting smoking.
Intervention: Treatment As Usual (Other)
Outcomes
Primary Outcomes
Number of Participants at Month 1 and Month 3 With At Least 1 Quit Attempt
Time Frame: Baseline through Month 3
quit attempts will be assessed at each follow-up using a timeline followback for the last 6-months at baseline and since prior follow-up for each subsequent assessment
Evidence-based Cessation Treatment Utilization
Time Frame: Baseline through Month 3
participants in both groups will be queried for use of a smoking cessation medication since the last assessment
Secondary Outcomes
- E-visit Acceptability and Feasibility(Baseline through Month 3)
Investigators
Jennifer Dahne
Assistant Professor
Medical University of South Carolina